VAMP7 Gene

VAMP7 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">VAMP7 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>VAMP7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Vesicle-Associated Membrane Protein 7</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>TI-VAMP, SYBL1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq28</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6845</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000125459</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UBW5</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>300301</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>SNARE protein; Vesicle trafficking</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's disease, Parkinson's disease, Hermansky-Pudlak syndrome</td>
</tr>
</table>

VAMP7 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">VAMP7 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>VAMP7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Vesicle-Associated Membrane Protein 7</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>TI-VAMP, SYBL1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq28</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6845</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000125459</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UBW5</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>300301</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>SNARE protein; Vesicle trafficking</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's disease, Parkinson's disease, Hermansky-Pudlak syndrome</td>
</tr>
</table>

VAMP7 (Vesicle-Associated Membrane Protein 7), also known as TI-VAMP (Tetratricopeptide-Vesicle Associated Membrane Protein), is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) family. Located on chromosome Xq28, VAMP7 is a longin domain-containing v-SNARE protein that plays critical roles in intracellular vesicle trafficking, including regulated exocytosis, endocytosis, lysosomal fusion, and [autophagy](/mechanisms/autophagy). VAMP7 is essential for [synaptic vesicle](/proteins/synapsin) release, neuronal development, and has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and Hermansky-Pudlak syndrome.

Pathway / Interaction Diagram

Overview

Gene Structure

The VAMP7 gene spans approximately 35 kb and consists of 13 exons encoding a 219-amino acid protein. The gene is located on the X chromosome and undergoes alternative splicing to generate multiple isoforms with tissue-specific expression patterns.

Protein Structure

VAMP7 contains several functional domains:

The unique longin domain distinguishes VAMP7 from other VAMP family members (VAMP1, VAMP2) and contributes to its specialized functions in regulated exocytosis and lysosomal trafficking.

Function

SNARE Complex Formation

VAMP7 functions as a v-SNARE (vesicle SNARE) in intracellular membrane fusion events:

• SNARE pairing — VAMP7 forms trans-SNARE complexes with target SNAREs (t-SNAREs) like syntaxins
• Membrane fusion — The SNAREpin brings vesicle and target membranes together, driving fusion
• Specificity — VAMP7 interacts with specific t-SNAREs, determining trafficking specificity

Regulated Exocytosis

VAMP7 is involved in several exocytic pathways:

• Synaptic vesicle release — VAMP7 contributes to neurotransmitter release at synapses
• Lysosomal exocytosis — VAMP7 mediates Ca²⁺-triggered lysosomal fusion with the plasma membrane
• Secretory granule release — VAMP7 participates in regulated secretion from specialized granules

Endosomal Trafficking

VAMP7 plays critical roles in endosomal system function:

• Endolysosomal fusion — VAMP7 mediates fusion between late endosomes and lysosomes
• Autophagosome-lysosome fusion — VAMP7 is required for autophagic flux
• Cargo trafficking — VAMP7 ensures proper delivery of cargo to degradation compartments

Autophagy

VAMP7 is a key player in [autophagy](/mechanisms/autophagy):

• Autophagosome formation — VAMP7 participates in early autophagic events
• Autophagosome-lysosome fusion — Essential for the final step of autophagy
• Lysosomal function — VAMP7 maintains lysosomal membrane integrity

Neuronal Functions

In neurons, VAMP7 supports:

• Synaptic vesicle cycling — VAMP7 participates in synaptic vesicle exocytosis and recycling
• Neurite outgrowth — VAMP7-mediated trafficking supports axonal and dendritic growth
• Dendritic spine formation — VAMP7 contributes to synaptic junction assembly

Brain Expression

VAMP7 is expressed throughout the brain:

• Cerebral cortex — Pyramidal neurons and interneurons
• Hippocampus — CA1-CA3 regions, dentate gyrus ([memory](/diseases/alzheimers-disease))
• Cerebellum — Purkinje cells
• Substantia nigra — [Dopaminergic neurons](/diseases/parkinsons-disease)
• Hippocampal neurons — High expression in synaptic regions

Regulation

VAMP7 activity is tightly regulated:

• Longin domain autoinhibition — The longin domain keeps VAMP7 inactive until needed
• Calcium sensing — Ca²⁺ influx triggers VAMP7-mediated exocytosis
• Phosphorylation — Kinases modulate VAMP7 SNARE assembly
• Interaction with accessory proteins — Munc13, Munc18, and other regulators control VAMP7

Disease Associations

Alzheimer's Disease

VAMP7 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through:

• Amyloid-beta secretion — VAMP7 participates in Aβ release through exocytosis
• Neuronal trafficking disruption — VAMP7 dysfunction affects axonal transport
• Lysosomal impairment — VAMP7 deficiency contributes to lysosomal dysfunction
• Synaptic loss — VAMP7 alterations affect synaptic integrity

Parkinson's Disease

VAMP7 may contribute to [Parkinson's disease](/diseases/parkinsons-disease) through:

• Alpha-synuclein secretion — VAMP7-mediated exocytosis contributes to α-syn spread
• Lysosomal dysfunction — VAMP7 alterations affect autophagic-lysosomal pathway
• Dopaminergic neuron vulnerability — VAMP7 is expressed in substantia nigra neurons
• Membrane trafficking — VAMP7 dysfunction affects dopamine release

Hermansky-Pudlak Syndrome

VAMP7 mutations cause a form of HPS:

• Lysosomal trafficking defects — Impaired lysosome-related organelle function
• Oculocutaneous albinism — Melanocyte dysfunction
• Bleeding diathesis — Platelet dense granule defects
• Immunodeficiency — Immune cell dysfunction

Other Neurodegenerative Conditions

• Amyotrophic lateral sclerosis[@vamp7_als] — VAMP7 in motor neuron function. Altered VAMP7 expression in ALS spinal cord.
• Huntington's disease[@vamp7_huntington] — Altered VAMP7 in striatal neurons. VAMP7 dysfunction may contribute to vesicular trafficking defects.
• Neuronal ceroid lipofuscinoses[@vamp7_ncl] — Lysosomal trafficking defects. VAMP7 affects lysosome-related organelle function.

Molecular Mechanisms

SNARE Complex Assembly

VAMP7 participates in SNARE complex formation:

Longin Domain Regulation

The longin domain controls VAMP7 activity[@vamp7_signaling]:

• Autoinhibition — The longin domain binds the SNARE motif, preventing assembly
• Activation — Triggering events (Ca²⁺, phosphorylation) release inhibition
• Interaction specificity — The longin domain determines partner selection
• Regulation by phosphorylation — Casein kinases and other kinases modulate VAMP7

Calcium-Dependent Exocytosis

VAMP7 mediates Ca²⁺-triggered exocytosis[@vamp7_exocytosis]:

• Synaptotagmin binding — VAMP7 interacts with synaptotagmin VII
• Calcium sensing — Ca²⁺ influx triggers VAMP7-mediated fusion
• Fusion pore dynamics — VAMP7 regulates fusion pore formation

Detailed Disease Mechanisms

Alzheimer's Disease

VAMP7 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease)[@vamp7_ad]:

Amyloid-beta secretion: VAMP7 participates in Aβ release through exocytosis. Amyloid precursor protein (APP) processing involves VAMP7-mediated vesicular trafficking.

Neuronal trafficking disruption: VAMP7 dysfunction affects axonal transport. Impaired VAMP7 leads to cargo accumulation and trafficking jams.

Lysosomal impairment: VAMP7 deficiency contributes to lysosomal dysfunction. Lysosomal cathepsin activity is affected in AD.

Synaptic loss: VAMP7 alterations affect synaptic integrity. Synaptic vesicle numbers are reduced with VAMP7 dysfunction.

Tau pathology connections: VAMP7 may interact with tau pathways. Both proteins are involved in vesicular trafficking.

Parkinson's Disease

VAMP7 may contribute to [Parkinson's disease](/diseases/parkinsons-disease)[@vamp7_pd]:

Alpha-synuclein secretion: VAMP7-mediated exocytosis contributes to α-syn spread. Extracellular α-syn can be taken up by neighboring neurons.

Lysosomal dysfunction: VAMP7 alterations affect autophagic-lysosomal pathway. PINK1/Parkin mitophagy intersects with VAMP7 function.

Dopaminergic neuron vulnerability: VAMP7 is expressed in substantia nigra neurons. Unique vulnerability of these neurons may involve trafficking defects.

Membrane trafficking: VAMP7 dysfunction affects dopamine release. Synaptic vesicle dynamics are impaired.

Hermansky-Pudlak Syndrome

VAMP7 mutations cause a form of HPS[@vamp7_hps]:

• Lysosomal trafficking defects — Impaired lysosome-related organelle function
• Oculocutaneous albinism — Melanocyte dysfunction
• Bleeding diathesis — Platelet dense granule defects
• Immunodeficiency — Immune cell dysfunction
• Pulmonary fibrosis — Lung involvement in some cases

Therapeutic Implications

VAMP7 is a potential therapeutic target for[@vamp7_therapy]:

Neurodegenerative diseases: Modulating VAMP7 may improve neuronal trafficking. Enhancing VAMP7 function could protect synaptic function.

Lysosomal disorders: VAMP7-targeted approaches could treat HPS. Gene therapy to restore VAMP7 function.

Cancer: VAMP7 inhibitors may block tumor exocytosis. VAMP7 is overexpressed in some cancers.

Therapeutic Approaches

• SNARE modulators — Develop compounds that enhance or inhibit VAMP7 SNARE activity
• Calcium channel modulators — Affect VAMP7-mediated exocytosis
• Gene therapy — Restore VAMP7 function in deficiency states
• Small molecule enhancers — Improve VAMP7 trafficking function

Biomarker Potential

• VAMP7 expression as marker of synaptic health
• CSF VAMP7 levels in neurodegeneration
• VAMP7 genetic variants as risk modifiers

Research Directions

Key Questions

Emerging Research

• VAMP7 in tau propagation: Does VAMP7 mediate spread of tau pathology?
• VAMP7 and mitochondrial quality control: Connections to mitophagy
• VAMP7 in neuroinflammation: Role of exosomal release

See Also

• [SNARE Proteins](/mechanisms/snare-proteins)
• [Synaptic Vesicles](/proteins/synapsin)
• [Lysosomes](/mechanisms/lysosomal-function)
• [Autophagy](/mechanisms/autophagy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Transmission](/mechanisms/synaptic-transmission)

Structural Biology of VAMP7

Longin Domain Structure

The N-terminal longin domain of VAMP7 is approximately 120 amino acids and adopts a fold resembling the LONGIN domain family structure[@vamp7_signaling]. This domain serves critical regulatory functions:

• [α-helical structure*: Multiple α-helices arranged in a compact fold](/genes/ran)
• [SNARE motif binding*: The longin domain physically interacts with the SNARE motif](/genes/ar)
• [Autoinhibitory conformation*: Maintains VAMP7 in a closed, inactive state](/genes/vamp7)
• [Phosphorylation sites*: Serine and threonine residues for regulatory phosphorylation](/companies/reo)

SNARE Motif and Transmembrane Domain

The SNARE motif (amino acids 1-60) contains:

• Heptad repeats: Characteristic coiled-coil forming sequences
• Ionic zero layer: Central arginine (R) residue critical for complex formation
• Hypervariable region: Determines pairing specificity

• Single α-helix: Spans the membrane
• Membrane anchoring: Essential for vesicle localization
• Palmitoylation: Some isoforms show additional lipid modifications

VAMP7 in Synaptic Function

Synaptic Vesicle Cycling

VAMP7 participates in multiple stages of synaptic vesicle cycling[@vamp7_synapse]:

Unlike VAMP2 (synaptobrevin-2), VAMP7 contributes to a distinct pool of synaptic vesicles.

Activity-Dependent Regulation

VAMP7 function is modulated by neuronal activity:

• Phosphorylation: CaMKII and PKA phosphorylate VAMP7
• Calcium sensitivity: Direct Ca²⁺ binding enhances fusion
• Trafficking dynamics: Activity-dependent mobilization of VAMP7 pools

VAMP7 in Autophagy

Autophagosome Formation

VAMP7 contributes to autophagosome biogenesis[@vamp7_autophagy]:

• Isolation membrane: VAMP7 localizes to nascent autophagosomes
• ER contact sites: Coordinates with ER for membrane expansion
• Atg proteins: Interacts with Atg14 and other autophagy proteins

Lysosomal Fusion

The final step of autophagy requires VAMP7-mediated fusion[@vamp7_lysosome]:

Autophagy in Neuronal Health

Neuronal autophagy is particularly important due to:

• Post-mitotic nature: Neurons cannot dilute protein aggregates
• High metabolic demand: Requires efficient clearance mechanisms
• Axonal complexity: Autophagy needed in distant terminals

Therapeutic Targeting of VAMP7

Small Molecule Modulators

Developing VAMP7-targeted therapeutics faces challenges:

• SNARE complex modulators: Affects multiple SNARE proteins
• Calcium channel modifiers: Alters exocytosis broadly
• Phosphorylation inhibitors: Targets upstream regulators

Gene Therapy Approaches

VAMP7 gene therapy shows promise:

• AAV vectors: Deliver functional VAMP7 to neurons
• CRISPR editing: Correct pathogenic mutations
• RNAi: Reduce harmful overexpression in certain contexts

Biomarker Potential

VAMP7 as a biomarker:

• CSF measurement: VAMP7 cleavage products in disease
• Expression studies: Altered VAMP7 in neurodegenerative brains
• Genetic variants: SLC48A1 polymorphisms and disease risk

VAMP7 in Specific Neuronal Populations

Dopaminergic Neurons

In substantia nigra pars compacta neurons:

• High VAMP7 expression
• Critical for dopamine vesicle trafficking
• Affected in PD models

Hippocampal Neurons

VAMP7 in hippocampal circuits:

• Regulates synaptic plasticity
• Important for memory formation
• Altered in AD models

Cortical Pyramidal Neurons

Cortical VAMP7:

• Participates in excitatory neurotransmission
• Controls dendritic vesicle trafficking
• Contributes to cortical connectivity

VAMP7 and Other Neurodegeneration Genes

Interactions with PD Genes

VAMP7 intersects with multiple PD genes:

• LRRK2: Modulates VAMP7 trafficking
• GBA: Lysosomal function affects VAMP7
• SNCA: Alpha-synuclein impairs VAMP7 function
• PINK1/Parkin: Mitophagy pathways intersect

Network Effects

VAMP7 participates in cellular networks:

• SNARE machinery: Core fusion proteins
• Autophagy-lysosome pathway: Final degradation step
• Endolysosomal system: Intracellular trafficking

Research Models

Cellular Models

• VAMP7 knockout cells: Loss-of-function studies
• Patient-derived iPSCs: Neurons with VAMP7 variants
• Overexpression systems: Gain-of-function analysis

Animal Models

• VAMP7 knockout mice: Show partial viability
• Conditional knockouts: Brain-specific deletion
• Disease models: Transgenic PD/AD backgrounds

Biochemical Studies

• SNARE complex reconstitution: Purified components
• Live-cell imaging: VAMP7 trafficking dynamics
• Cryo-EM: High-resolution SNARE structures

Emerging Research Questions

Key Unresolved Questions

Future Directions

• Structural studies: High-resolution VAMP7 structures
• Single-cell analysis: Neuron-type specific functions
• Clinical translation: Biomarker and therapeutic development

External Links

• [NCBI Gene: VAMP7](https://www.ncbi.nlm.nih.gov/gene/6845)
• [UniProt: VAMP7](https://www.uniprot.org/uniprot/Q9UBW5)
• [OMIM: 300301](https://omim.org/entry/300301)
• [Allen Brain Atlas](https://human.brain-map.org/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving VAMP7 Gene discovered through SciDEX knowledge graph analysis: